Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB06168Canakinumab1Completed1
DB16250Nazartinib1Completed1
DB14892Spartalizumab1Completed1
DB08911Trametinib1Completed1